Difficulty: Medium
Average Score: 70%
Practice
Which of the following is a selective MAO-B inhibitor?
Correct answer
A
Rationale
The correct answer is A) Selegiline, a selective MAO-B inhibitor. Selegiline specifically targets and inhibits the MAO-B enzyme, which predominantly metabolizes dopamine in the brain. By selectively inhibiting MAO-B, selegiline increases dopamine levels in the brain, making it a valuable treatment for Parkinson's disease.
Option B) Chlorgiline is not a valid choice as it is not a known drug in CNS pharmacology. Option C) Moclobemide is a reversible inhibitor of MAO-A, not MAO-B. It is used to treat depression and anxiety disorders. Option D) Tranylcypromine is a non-selective MAO inhibitor, inhibiting both MAO-A and MAO-B, and is commonly used in the treatment of depression.
Understanding the differences between MAO inhibitors is crucial in pharmacology, especially in managing CNS disorders. Selective MAO-B inhibitors like selegiline offer a more targeted approach with potentially fewer side effects compared to non-selective MAO inhibitors. This knowledge is essential for healthcare professionals to make informed decisions when selecting appropriate pharmacological interventions for patients with CNS conditions.
Option B) Chlorgiline is not a valid choice as it is not a known drug in CNS pharmacology. Option C) Moclobemide is a reversible inhibitor of MAO-A, not MAO-B. It is used to treat depression and anxiety disorders. Option D) Tranylcypromine is a non-selective MAO inhibitor, inhibiting both MAO-A and MAO-B, and is commonly used in the treatment of depression.
Understanding the differences between MAO inhibitors is crucial in pharmacology, especially in managing CNS disorders. Selective MAO-B inhibitors like selegiline offer a more targeted approach with potentially fewer side effects compared to non-selective MAO inhibitors. This knowledge is essential for healthcare professionals to make informed decisions when selecting appropriate pharmacological interventions for patients with CNS conditions.